Cite
In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model.
MLA
Igarashi, Yuki, et al. “In Vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren Pivoxil against S. Pneumoniae in Murine Lung-Infection Model.” Pharmaceutical Research, vol. 40, no. 7, July 2023, pp. 1789–97. EBSCOhost, https://doi.org/10.1007/s11095-023-03539-4.
APA
Igarashi, Y., Kojima, N., Takemura, W., Liu, X., Morita, T., Mizukami, Y., Enoki, Y., Taguchi, K., Yokoyama, Y., Nakamura, T., & Matsumoto, K. (2023). In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model. Pharmaceutical Research, 40(7), 1789–1797. https://doi.org/10.1007/s11095-023-03539-4
Chicago
Igarashi, Yuki, Nana Kojima, Wataru Takemura, Xiaoxi Liu, Takumi Morita, Yuki Mizukami, Yuki Enoki, et al. 2023. “In Vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren Pivoxil against S. Pneumoniae in Murine Lung-Infection Model.” Pharmaceutical Research 40 (7): 1789–97. doi:10.1007/s11095-023-03539-4.